Fortress Biotech, Inc. (NASDAQ:FBIOP – Get Free Report)’s share price rose 22.9% during mid-day trading on Monday . The stock traded as high as $13.79 and last traded at $13.52. Approximately 205,100 shares were traded during mid-day trading, an increase of 583% from the average daily volume of 30,009 shares. The stock had previously closed at $11.00.
Fortress Biotech Trading Up 22.9%
The stock’s fifty day moving average is $11.02 and its 200 day moving average is $8.82.
Fortress Biotech Company Profile
Fortress Biotech, Inc (NASDAQ: FBIOP) is a biopharmaceutical company that acquires, develops and commercializes innovative therapeutics for the treatment of patients with serious diseases. Operating as a biotech accelerator, Fortress Biotech partners with experienced management teams to advance products from early-stage discovery through regulatory approval and commercial launch. Its diversified portfolio spans multiple therapeutic areas, including oncology, rare diseases, dermatology, ophthalmology and neuromuscular disorders.
The company’s business model centers on establishing and funding product-centric subsidiary companies, each focused on a specific drug candidate or therapy.
Featured Articles
- Five stocks we like better than Fortress Biotech
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Elon Musk: This Could Turn $100 into $100,000
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- REVEALED: Something Big Happening Behind White House Doors
Receive News & Ratings for Fortress Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fortress Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
